by JAAPA
The podcast for the Journal of the American Academy of Physician Assistants
Language
🇺🇲
Publishing Since
5/8/2017
Email Addresses
1 available
Phone Numbers
0 available
April 10, 2025
<p class="MsoNormal" style= "margin-bottom: 0in; line-height: normal; vertical-align: baseline;"> <span style= "font-family: 'Aptos',sans-serif; color: #212121; background: white;"> Why is advanced care planning so important, and how can PAs make a difference? Tune in to the latest JAAPA podcast episode with guest Christa Cooper to explore the innovative research she and her colleague Jessica Karl conducted on Telemedicine Advanced Care Planning led by Physician Associates. Discover how this approach enhances communication, reduces burdens on families, and ensures patient preferences are honored. Get the details and earn CME credit at </span><a title= "Original URL: http://cme.aapa.org/. Click or tap if you trust this link." href= "https://nam04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fcme.aapa.org%2F&data=05%7C02%7Cjonathan.scovner%40wolterskluwer.com%7Cc6221d79e50a4a2f04c508dd721dc4ab%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638792194386882338%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=ZFkNmP%2B%2B%2FFRTGiIaMi0kVZazklPMJwZdU0857gNS8Rs%3D&reserved=0" target="_blank" rel="noopener"><span style= "font-family: 'Aptos',sans-serif; color: #96607d; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in; background: white;">cme.aapa.org</span></a><span style="font-family: 'Aptos',sans-serif; color: #212121; background: white;">!</span></p>
March 4, 2025
<p>Valproic acid is one of the most frequently prescribed mood-stabilizing agents for bipolar disorder, and in some regions of the world, it now competes with lithium as the preferred treatment of choice for bipolar maintenance. There may soon be restrictions on the use of valproic acid, however, because of the risk in neural tube defects and major congenital malformations in children born to mothers and fathers who take it.</p> <p>In this podcast, Dr. Samuel Dotson, from the Northeast Georgia Health System in Gainesville, Georgia, and Emory University in Atlanta, and Dr. Andrew Nierenberg, from the Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital and Harvard Medical School, discuss the current state of research regarding the benefits and risks of valproic acid in comparison to lithium use. They also discuss the importance of informing patients about their options, noting that lithium use has sometimes been perceived as riskier than it is. Dr. Dotson and Dr. Nierenberg are the authors of a Guest Editorial titled <a href= "https://doi.og/10.1097/JCP.0000000000001948">“Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium”</a> in <a href= "https://journals.lww.com/psychopharmacology/toc/2025/03000">the March-April 2025 issue of The Journal of Clinical Psychopharmacology</a>.</p>
March 4, 2025
<p>Dr. Donald C. Goff, Marvin Stern professor of psychiatry at NYU Grossman School of Medicine, gives an overview of a new combination drug recently approved by the U.S. Food and Drug Administration for the treatment of schizophrenia. It will be marketed as Cobenfy, and its component active ingredients are xanomeline and trospium chloride, representing the first non-dopaminergic antipsychotic approved by the FDA. Dr. Goff briefly explores the decades of pharmaceutical treatment of schizophrenia and lays out the steps toward developing the new combination drug. He offers details on next steps, treatment, more extensive trials of the new drug, related approaches, and refers listeners to his editorial for prescribing information.</p> <p>His guest editorial, <a href= "https://doi.org/10.1097/JCP.0000000000001959">“At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy),”</a> is published in <a href= "https://journals.lww.com/psychopharmacology/toc/2025/03000">the March-April 2025 issue of The Journal of Clinical Psychopharmacology</a>.</p>
The Curbsiders Internal Medicine Podcast
Brittany Broski & Audioboom Studios
NPR
Hannah Berner & Paige DeSorbo
Hidden Brain, Shankar Vedantam
The New York Times
The Daily Wire
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.